The antimicrobial peptide LL-37 promotes the migration of breast cancer cells via PI3K/AKT signaling and increases intracellular Ca2+ levels via Transient Receptor Potential Cation Channel Subfamily V Member 2 (TRPV2). Here, AKT1 is linked to breast cancer.